AMENDMENT NO. 3 TO LICENSE AGREEMENTLicense Agreement • August 5th, 2021 • Arcus Biosciences, Inc. • Pharmaceutical preparations
This AMENDMENT NO. 3 (the “Amendment”) is made and entered into as of May 10, 2021 (“Effective Date”), by and between Arcus Biosciences, Inc. (“Arcus”), with offices at 3928 Point Eden Way, Hayward, CA 94545, U.S.A., and WuXi Biologics Ireland Limited (successor-in-interest to WuXi Biologics (Cayman) Inc., “WuXi Biologics”), with an address at One Spencer Dock, North Wall Quay, Dublin 1, Ireland. Arcus and WuXi Biologics may be referred to in this Amendment individually as a “Party” or together as the “Parties.”
July 16, 2021 Dear Bill:Separation Agreement • August 5th, 2021 • Arcus Biosciences, Inc. • Pharmaceutical preparations
This letter confirms the terms and conditions of your voluntary resignation of employment with Arcus Biosciences, Inc. (the “Company”), as well as the benefits the Company will provide to you in exchange for your consent to be bound by the terms of this letter agreement (“Agreement”).
